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PhD,c Thomas E. MacGillivray, MD,a Alan D. Hilgenberg, MD,a and Arvind K. Agnihotri, MDa
Objective: We sought to assess early and late survival and cardiovascular-specific mortality after surgical repair
of acute ascending aortic dissection and the effect of differences in surgical technique, patient characteristics, and
preoperative diagnostic testing.
Methods: Between 1979 and 2003, 195 consecutive patients underwent repair for acute ascending aortic dissec-
tion within 2 weeks of the onset of symptoms. Mean follow-up was 7.0  5.9 years (range, 0–26 years) and was
100% complete.
Results: Patients were aged 62 15 years on average and were mostly male (66%) and hypertensive (69%). Risk
of death early and late after the operation decreased over the study period, with hospital mortality decreasing from
21% to 4% when comparing the first and most recent quartiles (P ¼ .007, c2 test for trend). At 1, 5, 10, and 20
years postoperatively, survival was 84%, 69%, 55%, and 30%, respectively, and freedom from cardiovascular
death was 86%, 80%, 71%, and 51%, respectively. Additional independent risk factors for death were older age
(P<.001), renal dysfunction (P<.003), syncope (P¼ .007), and peripheral vascular disease (P¼ .006). During
the study period, echocardiographic and computed tomographic diagnostic imaging replaced routine aortic angio-
graphic analysis, and operative techniques involved more frequent use of open distal anastomoses, retrograde
cerebral perfusion, earlier restoration of antegrade perfusion, and a conservative approach to aortic arch repair.
Freedom from reoperation on the aorta or aortic valve was 93% and 84% at 5 and 10 years, respectively.
Conclusions: Early and late survival after repair of acute ascending aortic dissection has improved progressively
over 25 years in association with noticeable changes in preoperative and intraoperative management. Aortic re-
operations were infrequent during follow-up. (J Thorac Cardiovasc Surg 2009;138:1349-57)
Stevens et al Acquired Cardiovascular DiseaseSupplemental material is available online.
Patients presenting with ascending aortic dissection within 2
weeks of the onset of symptoms are considered to have acute
ascending aortic dissection (AAAD), whereas chronic pre-
sentation is defined when there is at least 2 weeks from the
onset of symptoms. The importance of this diagnostic time
frame is underscored by the reported 65% to 75% death
rate of patients associated with untreated AAAD.1 Hospital
mortality for repair of AAAD has decreased since the 40%
mortality rate reported by Debakey and colleagues in 19652
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porting long-term results after repair of AAAD, few reports
are based on a mean follow-up of greater than 5 years, with
10-year survival estimates ranging from 37% to
71%.4,7,8,19,20
This study sought to extend information regarding long-
term cardiovascular and all-cause survival after repair of
AAAD by means of review of the experience in a single
institution over a 26-year period. Additionally, we sought
to assess the effect of patient characteristics and explore
the changes in outcome over time that might have occurred




A retrospective study was undertaken of patients undergoing surgical
repair of AAAD from October 1979 to December 2003. A database of all
cardiac surgical operations performed at Massachusetts General Hospital
was queried for mention of aortic dissection. Two hundred seventy-three
patients were reviewed. We excluded 76 (28%) patients for the following
reasons: chronic dissection (n ¼ 35 [13%]), descending aortic dissection
(DeBakey type III/Stanford type B, n¼ 34 [12%]), and intraoperative aortic
dissection or traumatic aortic injuries (n ¼ 7 [3%]). Two patients, excluded
from this analysis, were considered inoperable after surgical exploration
because of extensive dissection in the descending aorta with multiple
rupture sites, cardiac arrest before cardiopulmonary bypass, or both. Theardiovascular Surgery c Volume 138, Number 6 1349




AAAD ¼ acute ascending aortic dissection
AAR ¼ ascending aortic replacement
CT ¼ computed tomography
final cohort consisted of 195 patients who underwent surgical intervention
for ascending aortic dissection within 2 weeks of symptom onset.
Patient demographics, comorbidities, operative details and postoperative
outcomes were extracted retrospectively by means of chart review (see
Appendix E1). Involvement of the aorta and its branches in the dissection
process was determined by means of preoperative imaging and intraopera-
tive assessment of the dissection process. Ascending aortic repair was
completed with conservative techniques adapted to the dissection extension
and involvement of the aortic valve, including ascending aortic replacement
(AAR) without aortic valve replacement if aortic valve reconstruction was
feasible or the disease process was limited to the ascending aorta above
the sinotubular junction, AAR with aortic valve replacement if the aortic
valve was dysfunctional and the aortic sinuses were not involved, and
AAR with composite root replacement otherwise.21 In general, aortic arch
repair was performed only when the intimal tear extended in the aortic
arch. Hemiarch repair was defined as a replacement that included the lesser
curvature of the aortic arch beyond the level of the innominate artery but did
not involve the aortic arch vessels. Total arch repair involved replacement of
the anterior and posterior aortic arch, with reimplantation of the branch ves-
sels either as an island or as individual branch grafts. Antegrade perfusion
refers to restoration of antegrade cerebral and corporal perfusion through
the aortic graft, aortic arch, or subclavian artery after distal aortic graft anas-
tomosis.
Survival follow-up data were obtained by linking to the National Death
Index for all patients up to December 31, 2005. Date and cause of death were
confirmed with National Death Index data. Aortic reoperation follow-up
was obtained by means of telephone interview, mailed questionnaires to
patients, queries to family and primary care physicians/cardiologists,
queries to patient records, and correspondence. Aortic reoperation was
defined as any surgical procedure performed on the thoracic or abdominal
aorta or aortic valve after patient discharge from index admission. Ethics
approval for this study was obtained from the institutional review board.
Hospital mortality included death during the hospitalization and death
within 30 days of the operation. Cardiovascular death included hospital
death for index admission and follow-up death caused by cardiac ischemic
disease, endocarditis, other cardiac valve diseases, or vascular disease,
including stroke and vascular surgery–related deaths. Hypertension was
recorded if the patient was given a clinical diagnosis of hypertension or
was treated with antihypertensive medication before the index admission.
Peripheral vascular disease comprised any known atheromatous involve-
ment of systemic arteries with the exception of the coronary arteries and
included cerebrovascular disease, abdominal aortic atheromatosis and/or
aneurysmal disease, intermittent claudication, or previous vascular surgery.
Marfan syndrome was defined according to the 1996 revised criteria,22 and
histopathologic confirmation was sought when possible. Most patients were
hypertensive after dissection. Cardiogenic shock was reported if the preop-
erative systolic blood pressure was less than 80 mm Hg, the cardiac index
was less than 1.8 mL/m2, or they required intravenous use of inotropes.
Patients were considered unstable if they experienced accelerating pain or
hemodynamic instability (uncontrollable hypertension or hypotension). Sal-
vage was applied if patients were undergoing cardiopulmonary resuscitation
en route to the operating room or before anesthesia induction.
Statistical Analysis
All statistical analyses were performed with SAS release 9.1 software
(SAS Institute, Inc, Cary, NC). Data are expressed as means  standard1350 The Journal of Thoracic and Cardiovascular Sudeviations or medians and ranges for continuous variables and as numbers
(percentages) for categorical variables. Univariate analyses included the
2-tailed Wilcoxon rank sum or t tests for continuous variables and the
Fisher’s exact test for discrete variables (see Appendix E1 for the list of vari-
ables). For continuous variables, the linearity assumptions were assessed for
all models and transformations considered, where appropriate. For multivar-
iate analyses, missing data were handled by means of dummy coding for
dichotomous covariates. Covariates with more than 5% missing data
were discarded from the multivariate analyses. There were no missing
data for continuous covariates. The stability of effect estimates in the final
model was assessed by completing a bootstrap procedure with 5000 random
samples of 195 patients chosen with replacement from the original dataset.
The standard deviations of the means of the bootstrap estimates were used to
test the original parameter estimates from the final model by means of a c2
test.
Several variables were strongly associated with the year of surgical
intervention (and with each other) and were, by necessity, excluded from
the multivariate analysis (see the Results section). These were related to
preoperative or treatment variables that became available during the study
period and thus might not have been possible or were very difficult to apply
in the early part of the series. To assess competing diagnostic or surgical
strategies across time, we defined mutually exclusive categories, such as an-
giographic analysis alone, angiographic analysis with computed tomo-
graphic (CT) scanning, angiographic analysis with echocardiographic
analysis, CT scanning alone, and so on. As part of this exploratory analysis,
a multinomial logit model was fitted by using the categories as the outcome
variable and the date of surgical intervention as the independent variable,
thereby producing predicted probabilities across time, each representing
the likelihood of being assigned to one of the categories (and summing to
100% at each time point). Categories with a similar trend, few cases, or
both were combined if clinically meaningful, and the model was refitted.
Survival and aortic reoperation were estimated by using the Kaplan–Meier
technique, with log-rank tests to compare stratified groups. Time-specific
effects were estimated with parametric, multiphase (mixture distribution
components) hazard regression by using analytic tools available from the
Cleveland Clinic Heart Center Hazard Web site (http://www.cleveland
clinic.org/heartcenter/hazard/default.htm). A nonautomated directed tech-
nique of stepwise variable entry was used. Multiphase parametric hazard
regression was used, allowing assessment of the effect of baseline predictors
on different phases of follow-up separately. Kaplan–Meier and parametric
estimates of the survival of patients discharged alive (Weibull distribution)
were compared with the survival of a cohort from Massachusetts matched
for age, sex, and race by using 1989–1991 state lifetables.23 Risk factors
for aortic reoperation after discharge were assessed by using a Cox model.
RESULTS
Presentation
Patient characteristics, operative data, aortic repair tech-
niques, and concomitant procedures are reported in Table
1. Twenty-seven (14%) patients had prior aortic disease;
25 (13%) patients had prior aortic valve dysfunction, a bi-
cuspid aortic valve, or both; and 31 patients had prior car-
diovascular surgery (7 underwent coronary artery bypass
grafting, 10 underwent valve surgery, 10 underwent major
vascular surgery, and 4 underwent other procedures). Thir-
teen (7%) patients were given diagnoses of Marfan syn-
drome. Electrocardiographic findings were most often
nonspecific (44%), but 42 (23%) patients presented with ei-
ther ST-segment elevation or depression. Nineteen (10%)
patients underwent coronary artery catheterization before
surgical intervention.rgery c December 2009
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DTABLE 1. Patient characteristics, operative data, and hospital mortality
Hospital mortality*
Overall Exposed Unexposed Odds ratio (95% CI) P value
Overall 195 (100%) 26/195 (13%) – – –
Patient characteristics
Age (y) 62  15 – – 1.84y (1.26–2.70) .002
Male sex 128 (66%) 16/128 (13%) 10/67 (15%) 0.81 (0.35–1.91) .6
Hypertension 134 (69%) 21/134 (16%) 5/61 (8%) 2.08 (0.75–5.81) .2
Coronary artery disease 32 (16%) 6/32 (19%) 20/163 (12%) 1.65 (0.60–4.50) .3
Chronic lung disease 23 (12%) 6/23 (26%) 20/172 (12%) 2.68 (0.95–7.60) .06
Peripheral vascular disease 38 (19%) 5/38 (13%) 21/157 (13%) 0.98 (0.34–2.80) >.9
Serum creatinine (mg/dL) level
at admission
1.24  0.51 – – 2.47 (1.26–4.84) .009
Prior cardiac valve dysfunction 35 (18%) 3/35 (9%) 23/160 (14%) 0.56 (0.16–1.97) .4
Presenting symptoms
Sudden-onset pain 144/190 (76%) 18/144 (13%) 8/46 (17%) 0.68 (0.27–1.68) .4
Anterior chest pain 143/190 (75%) 17/143 (12%) 9/47 (19%) 0.57 (0.23–1.38) .2
Head/neck pain 45/190 (24%) 3/45 (7%) 23/145 (16%) 0.38 (0.11–1.33) .1
Back pain 93/190 (49%) 10/93 (11%) 16/97 (16%) 0.61 (0.26–1.42) .3
Abdominal pain 39/190 (21%) 3/39 (8%) 23/151(15%) 0.46 (0.13–1.63) .2
Clinical status
Hemodynamic status .02
Stable (reference) 112 (57%) 9/112 (8%) – 1
Unstable 71 (36%) 13/71 (18%) – 2.57 (1.03–6.37)
Salvage 12 (6%) 4/12 (33%) – 5.72 (1.44–22.75)
Cardiogenic shock 45 (23%) 11/45 (24%) 15/150 (10%) 2.91 (1.23–6.91) .02
Tamponade 26 (13%) 6/26 (23%) 20/169 (12%) 2.24 (0.80–6.23) .1
Syncope 33 (17%) 12/33 (36%) 14/162 (9%) 6.04 (2.47–14.80) <.001
Altered mental status 23 (12%) 5/23 (22%) 21/172 (12%) 2.00 (0.67–5.95) .2
Focal neurologic
deficit preoperatively
12 (6%) 3/12 (25%) 23/183 (13%) 2.32 (0.58–9.20) .2
ECG ST—segment elevation
or ST—segment depression
42/186 (23%) 8/42 (19%) 17/144 (12%) 1.76 (0.70–4.42) .2
Arteries involved in the dissection process
DeBakey type I 162 (83%) 20/162 (12%) 6/33 (18%) 0.63 (0.23–1.72) .4
DeBakey type II 33 (17%) 6/33 (18%) 20/162(12%) 1.58 (0.58–4.29)
Coronary arteries 40 (21%) 6/40 (15%) 20/155 (13%) 1.19 (0.44–3.20) .7
Carotid arteries 43 (22%) 8/43 (19%) 18/152 (12%) 1.70 (0.68–4.24) .3
Surgical data
Interval symptom–operation (h) 24 (0.9–480) – – 1.01 (0.90–1.14) .9
CPB time (min) 166  70 – – 1.02z (0.96–1.07) .6
Crossclamp time (min) 108  44 – – 0.93z (0.83–1.05) .2
Circulatory arrest time (min) 32  15 – – 0.81z (0.54–1.23) .3
Open distal anastomosis 146 (75%) 15/146 (10%) 11/49 (22%) 0.40 (0.17–0.93) .03
Retrograde cerebral perfusion 24 (12%) 0/24 (0%) 26/171 (15%) – –
Antegrade cerebral perfusion
through arch or graft
56 (29%) 5/56 (9%) 21/139 (15%) 0.55 (0.20–1.54) .3
Concomitant hemiarch repair 18 (9%) 2/18 (11%) 24/177 (14%) 0.80 (0.17–3.69) .8
Concomitant total arch repair 5 (3%) 1/5 (20%) 25/190 (13%) 1.65 (0.18–15.36) .7
Concomitant CABG 14 (7%) 3/14 (21%) 23/181 (13%) 1.87 (0.49–7.22) .4
Antifibrinolytic use (aprotinin
or aminocaproic acid [Amicar])
108 (55%) 7/108 (6%) 19/87 (22%) 0.25 (0.10–0.62) .003
Surgical glue use 44 (23%) 1/44 (2%) 25/151 (17%) 0.12 (0.02–0.89) .04
Year of operation (since October 1, 1979) 15  7 – – 0.65x (0.48–0.88) .005
CI, Confidence interval; ECG, electrocardiography; CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting. *Hospital mortality in patients exposed (presence of) or
unexposed (absence of) to each categorical risk factor (eg, male vs female sex or hypertensive vs nonhypertensive) with corresponding odds ratios and univariable P values from
logistic regression models. yEffect for 10-year difference in age. zEffect for 10-minute difference in cardiopulmonary bypass, crossclamp, or circulatory arrest times. xEffect for 5-
year difference in year of operation.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 6 1351




Ascending aortic and aortic valve surgical procedures-
included 137 (60%) ascending aortic grafts, including aortic
valve resuspension; 47 (24%) composite valve and ascend-
ing aortic grafts (39 mechanical and 8 biologic valves); 9
(5%) ascending aortic grafts and aortic valve replacements
(6 mechanical and 3 biologic valves); and 2 primary repairs
(aneurysmoplasty without aortic graft). The average ascend-
ing aortic graft was 28  3 mm, and the median aortic valve
replacement size was 27 mm (range, 19–31 mm).
Initial arterial cannulation was most commonly performed
at the femoral artery (96%) and rarely at the axillary artery
(2%) or aortic arch (2%). Venous cannulation was per-
formed by using a 2-staged right atrial canula (64%) or bi-
caval cannulas (26%), through the femoral vein (31%), or
both. Most patients (98%) were given cold intermittent
blood cardioplegia (98%), and 3 (2%) patients received
warm continuous blood cardioplegia. Hypothermic circula-
tory arrest was used in 148 (76%) patients, and the circula-
tory arrest lasted 32  15 minutes, with a minimal core
temperature of 17C  4C.
Early Results
Hospital mortality over the entire study period was 13%
(26 patients) but improved dramatically during the study in-
terval. When the study period was divided into 4 equal sub-
groups of consecutive patients, we observed a gradual
decrease in hospital mortality: 21% (10/48, 1979–1990),
18% (9/49, 1990–1996), 10% (5/49, 1996–2000), and
4% (2/49, 2000–2003; P ¼ .007, c2 test for trend). Intrao-
perative deaths occurred in 6 patients (23% of deaths) and
were due to uncontrollable hemorrhage (n¼ 3), post–cardio-
pulmonary bypass heart failure (n ¼ 2), or pulmonary artery
rupture (m ¼ 1). Postoperative deaths were caused by heart
failure (n ¼ 3), massive hemorrhage (n ¼ 2), stroke (n ¼ 9),
renal failure (n ¼ 1), and multiple system failure (n ¼ 5).
Univariate predictors for hospital mortality are presented
in Table 1. Independent predictors of hospital mortality are
reported in Table 2.*
In-hospital complications included cardiac reoperation in
35 (18%) patients, delirium in 50 (26%) patients, persistent
neurologic dysfunction in 37 (19%) patients, pneumonia
documented by positive sputum culture and chest imaging
in 42 (22%) patients, pleural effusion in 37 (19%) patients,
and temporary or permanent dialysis in 18 (9%) patients.
Most patients received transfusion of packed red blood cells
(use, 92%; median, 6 units), platelets (use, 82%; median, 15
* Marfan syndrome was initially selected as a significant independent predictor of hos-
pital mortality (odds ratio, 24.61; 95% confidence interval, 2.08–291.1; P ¼ .01),
but the variable was ultimately dropped from the list of independent risk factors after
we found that the stability of this estimate was in question. With the bootstrap pro-
cedure, the variable was rejected with a P value of .25; all other estimated P values
remained significant at a P value of less than .001. The final model had a c-statistics
of 0.85 and a Hosmer–Lemeshow goodness-of-fit test P value of .6.1352 The Journal of Thoracic and Cardiovascular Suunits), and fresh frozen plasma or cryoprecipitate (use, 86%;
median, 8 units). Patients with stroke had a longer postoper-
ative length of stay (P ¼ .02), and their hospital mortality
was 2.3 times higher compared with that seen in patients
without stroke (24% vs 11%, P¼ .03). Independent predic-
tors of postoperative stroke are listed in Table 3. The mean
maximum postoperative creatinine level was 2.3  2.0
mg/dL and decreased to 1.3  1.0 mg/dL on discharge or
death. Hospital mortality was 2.9 times higher among pa-
tients requiring dialysis postoperatively compared with
those who did not undergo dialysis (33% vs 11%, P ¼
.02). Of the 169 patients discharged alive, 93 (55%) were
discharged home, including 24 who were visited by a nurse,
with the remaining 76 (45%) patients discharged to a reha-
bilitation center.
Long-Term Survival
The mean follow-up was 7.0 5.9 years (range, 1 day–26
years), or 8.1  5.6 years in patients discharged alive, and
was 100% complete. Overall survival was 84%, 69%,
55%, 48%, and 30% at 1, 5, 10, 15, and 20 years, respec-
tively, and freedom from cardiovascular death was 86%,
80%, 71%, 67%, and 51% at 1, 5, 10, 15, and 20 years, re-
spectively (Figure 1). Figure 1 also shows the high early risk
of death followed by a low but slowly increasing late hazard
phase. Late deaths were due to ischemic cardiac diseases (n
¼ 14 [22%]); cerebrovascular disease (n ¼ 4 [6%]); vascu-
lar diseases (n ¼ 14 [22%]); cardiac valve diseases, includ-
ing endocarditis (n ¼ 4 [6%]); pulmonary diseases (n ¼ 6
[10%]); septicemia (n ¼ 3 [5%]); cancer (n ¼ 9 [15%]),
gastrointestinal diseases (n ¼ 4 [6%]); external causes/acci-
dents (n¼ 3 [5%]); and other unrelated causes of death (n¼
2 [3%]). Survival for patients discharged alive is compared
with an age-, sex-, and race-matched contemporary general
population in Figure E1.
Early- and late-phase multivariate predictors for all-cause
death and cardiovascular death are shown in Table 4. Note
that the independent predictors of mortality in the early haz-
ard phase included the same variables identified for hospital
mortality by using logistic methods, plus ‘‘salvage surgery’’
and ‘‘crossclamp time’’ for all-cause death or ‘‘involvement
of the carotid arteries’’ for cardiovascular death. The effect
of age on early and long-term survival is represented in Fig-
ure 2, A. Figure 2, B, shows the multivariable-adjusted 1-, 5-,
10-, and 15-year survival by year of surgical intervention.
Freedom From Aortic Reoperation
The mean aortic reoperation follow-up for patients dis-
charged alive was 6.7  5.8 years and was 91% complete
(16 patients lost to follow-up). Freedom from aortic reoper-
ation was 97%  1%, 93%  2%, 84%  4%, 66% 
8%, and 58%  10% at 1, 5, 10, 15, and 20 years, respec-
tively (Figure E2). Aortic reoperations included aortic valve
replacements (n ¼ 2 [8.3%]), composite root replacementsrgery c December 2009
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D(n ¼ 6 [25%]), arch repair (n ¼ 2 [8.3%]), thoracoabdomi-
nal aneurysm repairs (n ¼ 8 [33%]), abdominal aneurysm
repairs (n ¼ 4 [17%]), and surgical fenestrations of the ab-
dominal aorta (n ¼ 2 [8.3%]). Independent risk factors for
aortic reoperation included year of surgical intervention
(hazard ratio for 5-year increment, 2.30; 95% confidence in-
terval, 1.36–3.90; P ¼ .002) and Marfan syndrome (hazard
ratio, 5.97; 95% confidence interval, 2.22–16.0; P< .001).
Trends in Management
Several variables were correlated with later date of surgi-
cal intervention, including more sophisticated diagnostic im-
aging modalities, such as CT scanning (Pearson r ¼ 0.56)
and preprocedural transesophageal echocardiographic anal-
ysis (r ¼ 0.57), open distal anastomosis (r ¼ 0.73), ante-
grade cerebral perfusion (r ¼ 0.41), use of antifibrinolytic
agents (r ¼ 0.64), and use of biologic glue (r ¼ 0.51; all P
< .001). The time trend in competing diagnostic imaging
modality, circulatory arrest use and cerebral protection,
and surgical techniques used is shown in Figure 3. Overall,
aortic angiography was used in 97 (50%) patients, CT was
used in 112 (57%) patients, preprocedural transesophageal
echocardiography was used in 130 (67%) patients, and mag-
netic resonance imaging was used in 4 (2%) patients. There
was a trend toward more preservation of the aortic valve and
less aortic valve replacement (P¼ .05), whereas the percent-
age of composite root replacement remained stable.
DISCUSSION
Dissection of the ascending aorta remains one of the most
common emergency procedures in cardiac surgery. Despite
advances in stent graft technology, the relation of the as-
cending aorta to the aortic valve, coronary ostia, and arch
vessels has left open repair as the only treatment in all but
a few cases in select centers. Repair of AAAD typically in-
volves a palliation of a more extensive disease process. It is
uncommon that the operation removes the entire area of in-
volved vasculature, with the focused goal being only to halt
extension, improve branch flow, prevent rupture, and im-
prove aortic valve function. Since the early series of surgical
repair for AAAD,2 these goals have remained unchanged,
but changes have occurred with the incorporation of new
TABLE 2. Independent predictors of hospital death
Odds ratio (95% CI) P value





Syncope 4.66 (1.68–12.88) .003
Year of operation 0.54z (0.36–0.80) .002
CI, Confidence interval. *Natural logarithmic transformation of serum creatinine (in
milligrams per deciliter). yEffect for 10-year difference in age. zEffect for 5-year dif-
ference in year of operation.The Journal of Thoracic and Cpreoperative testing methods, mainly CT and echocardio-
graphic analysis, and use of improved techniques primarily
related to myocardial and cerebral protection strategies.
This study was undertaken to better characterize both the
effect of the evolution in management of this disease and the
long-term survival after surgical treatment. We report the
long-term results of aortic repair for AAAD over a 26-year
period in a single large-volume referral center.
Long-Term Survival
Few studies present greater than 15-year survival data af-
ter repair for AAAD. In the early to the late 1990s, Crawford
and associates,19 the Stanford group,20 and Bachet and col-
leagues4 reported 10- and 15-year survival ranging from
37% to 56% and 24% to 46%, respectively. Likewise,
we report 10-, 15-, and 20-year survival of 55%, 48%,
and 30%, respectively. The risk of death is markedly re-
duced after the perioperative period, although the survival
of patients discharged alive remains lower compared with
that of an age-, sex-, and race-matched general population.
Patient Factors Affecting Survival
Age is an established risk factor for early and late mortal-
ity.11,12,20 Some studies have focused on the outcomes of
surgical intervention for AAAD in patients older than 70
years.24,25 Elderly patients differ markedly from their youn-
ger counterparts in terms of comorbidities, such as long-
standing hypertension and atherosclerosis, and are more
likely to present in cardiogenic shock.
The extent of renal impairment measured based on serum
creatinine levels is a strong predictor of early mortality, as
also reported by others.3,18,20,26 Acute renal failure is associ-
ated with mesenteric ischemia, drug-resistant hypertension,
and aortic branch vessel compromise.26 Some have sug-
gested that delayed surgical intervention or medical treat-
ment with percutaneous fenestration or stenting has
acceptable early outcomes in the setting of severe renal or in-
testinal malperfusion.27,28 However, this strategy has to be
weighed against the increased risk of rupture, which is diffi-
cult to quantify, and generally poor results reported for med-
ical therapy.15,18
TABLE 3. Independent predictors of postoperative stroke
Odds ratio (95% CI) P value









With cerebral protection 1.33 (0.40–4.41) .5
CI, Confidence interval.ardiovascular Surgery c Volume 138, Number 6 1353
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DLate death was predicted based on peripheral vascular dis-
ease, which relates to the systemic involvement of arteries
and prior vascular surgery. Patients with extensive periph-
eral vascular disease might be unable to compensate for
reduced flow in the acute setting, leading to end-organ
malperfusion, with a significant toll on mortality.
Management Trends Associated With Improved
Outcomes
During this era, we observed incorporation of a variety of
new methods, an associated reduction in hospital mortality
from 21% in the early series to 4% recently, and improve-
ment in adjusted 5-year survival from 65% to 89%. We
identified factors associated with this improvement, the
most important of which were advances in diagnostic imag-
ing and improvement in ascending aortic repair techniques,
including liberal use of hypothermic circulatory arrest with
open distal anastomosis and cerebral protection techniques.
Diagnostic imaging modalities have undeniably improved
over the last 2 decades, with a shift from invasive procedures
with high contrast loads (aortography) to faster modalities
with low contrast loads (CT) or applicable at bedside
(echocardiography). As technology improved, aortography
was rarely requested as a unique modality and was gradually
combined with CT, preoperative echocardiography, or both.
As we move forward in the years of treatment, angiography
was seldom requested, whereas CT and echocardiography
were generally combined. The International Registry of
Acute Aortic Dissection29 and others30 have shown that all
diagnostic modalities have a high sensitivity for ascending
aortic dissection (CT, 93%–100%; transesophageal echo-
cardiography, 90%–98%; and aortography, 87%–88%),
but the false-negative rate is still considerable and mandates
more than 1 modality to conclusively exclude the diagnosis.
Magnetic resonance imaging was seldom used in our series.
Surgical techniques changed significantly during the
study period. The practice of hypothermic circulatory arrest,
visual inspection of the arch vessels, and open distal anasto-
mosis was introduced in the 1980s and became routine soon
afterward. In this series the initial arterial cannulation site of
FIGURE 1. Survival (A) and freedom from cardiovascular death (B) after
surgical intervention for all patients. Actuarial survival estimates with 1
standard deviation (68% confidence limits) and size of risk sets at 1, 5,
10, 15, and 20 years after surgical intervention are provided in the embedded
table. The predicted survival from each parametric multiphase model is
overlaid as a bold solid line in the same illustration, with a bold dashed
line indicating 1 standard deviation. The thin solid line represents the hazard
function (as percentage of death per year) for each model, with the dotted
line indicating 1 standard deviation. The left vertical axis represents percent-
age survival, and the right vertical axis represents percentage death per year.












1.7  0.57 .003
Syncope 1.1  0.41 .007
Salvage 1.3  0.57 .02
Crossclamp timey 1.7  0.74 .02
Year of operationz 0.5  0.15 <.001
Late hazard phase
Age 0.06  0.013 <.001
Peripheral vascular disease 1.0  0.34 .006









1.3  0.54 .02
Syncope 1.3  0.38 <.001
Involvement of the carotid arteries 1.0  0.42 .02
Year of operationz 0.4  0.13 .002
Late hazard phase
Age 0.07  0.023 .001
SD, Standard deviation. *Natural logarithmic transformation of serum creatinine (in
milligrams per deciliter). yNatural logarithmic transformation of crossclamp time (in
minutes). zSquared transformation of years since October 1, 1979.1354 The Journal of Thoracic and Cardiovascular Surgery c December 2009
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Dchoice was the femoral artery for rapid access and, more re-
cently, conversion to antegrade perfusion through the aortic
graft after distal anastomosis. Cerebral protection techniques
were introduced in the 1990s, and antegrade cerebral protec-
tion is now more popular. David and coworkers5 suggested
that avoidance of aortic crossclamping during cooling and
resection of the primary tear improved early and late out-
comes for AAAD. They further suggested a decrease in
the incidence of stroke with this technique, which was not
shown in this series. Instead, prior cerebral deficit, aortic
rupture into the pericardium, and use of circulatory arrest
without cerebral protection were shown to be independent
predictors of stroke. In patients undergoing circulatory arrest
and presenting without prior cerebral deficit or aortic rup-
ture, the use of simple cerebral protection techniques was as-
sociated with a trend toward a decrease in the rate of stroke
(21% to 11%, P ¼ .2). As antegrade perfusion techniques
have evolved, we tend to use more frequently the axillary ar-
tery or the aortic arch and its branches as the initial cannula-
tion site when the patient is hemodynamically stable.
Year of surgical intervention was also associated with
improved late survival in addition to the effect seen on early
survival. This might be related to better postoperative
follow-up of these complicated patients with extensive vas-
cular disease at specialized clinics or attentive follow-up
from others. Diagnostic imaging techniques are becoming
less invasive and more precise, both of which facilitate
repeated follow-up examinations. The earlier detection of
patients with vascular complications during follow-up and
aggressive treatment of patients with Marfan syndrome
might explain why patients are more likely to undergo an
aortic reoperation in the later part of the series. The overall
FIGURE 2. Multivariable-adjusted survival for patients aged 35, 50, 65,
and 80 years (A) and multivariable-adjusted 1-, 5-, 10-, and 15-year survival
by year of operation (B). Predictions are presented with 1 standard deviation
(68% confidence limits) and are truncated according to the maximum fol-
low-up observed in each group. In these models continuous variables are
fixed at their mean values (except for age in model A and year of operation
for model B), and binary variables are set to zero.
FIGURE 3. Changing patterns in management of acute ascending aortic
dissection. The depictions highlight changes observed during the study pe-
riod, with each curve representing the relative occurrence of mutually exclu-
sive management strategies over time, adding up to 100% at every time
point. Panel A demonstrates the change in use of preoperative diagnostic
imaging modalities. Angiography is replaced gradually with the incorpora-
tion of computed tomography (CT) and echocardiography (echo.). Panel B
depicts the increasing use of circulatory arrest and antegrade/retrograde ce-
rebral perfusion.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 6 1355
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Drisk of aortic reoperation was low and comparable with that
described in the published literature.4,7,8,12,20
Limitations
This study represents the experience of a large academic
referral center over a 26-year period with a mean
follow-up of 7.0  5.9 years, or 8.1  5.6 years in patients
discharged alive, and might not be generalizable to others
centers. As a referral center, many patients are transferred
some hours after the initial presentation, and there might
be some selection bias in the subpopulation of patients
who actually underwent surgical intervention, knowing
that there must have been a few who died or were deemed
inoperable at some point in their evaluation.
Aortic reoperation follow-up was limited. Also, informa-
tion regarding long-term outcome would ideally have in-
cluded additional information on the patient’s functional
status collected prospectively.
Attempts to understand the factors that lead to observed
changes over time were made difficult because of the fact
that multiple ‘‘new’’ variables were appearing during the
interval. These were highly correlated, and thus identifying
(or excluding) any individual factor was made statistically
impossible in some cases. Other factors might account for
the improved early and late survival, including earlier refer-
ral, improved intensive care unit performance, and second-
ary or tertiary prevention measures.
CONCLUSION AND CLINICAL INFERENCES
Over the past 25 years, early and late outcomes for AAAD
have improved in association with the incorporation of new
methods and technologies, including echocardiography, CT
imaging, use of open distal anastomosis, and improved
cerebral protection techniques. The reported current early
mortality of less that 5% was achieved by using a strategy
that emphasizes avoidance of coronary angiography, com-
bined use of CT and transesophageal echocardiographic
data, a meticulous surgical technique involving routine use
of hypothermic circulatory arrest with open distal anastomo-
sis, and a conservative approach to aortic arch repair.
We are grateful for the research assistance provided by Sandra
Debronkart, Karen E. Lynch, Jerene Bitondo, and Suyog Mokashi.
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Presentation: interval between symptom onset and surgi-
cal intervention, hemodynamic state at the time of the oper-
ation (stable, unstable, or cardiogenic shock), characteristic
of pain (sudden) and location (anterior, posterior, neck, ab-
dominal, or extremities), altered mental status, focal neuro-
logic deficit, paraplegia, syncope
Status of aorta: known extent of dissection (ascending or
descending coronary arteries or carotid arteries), aortic valve
regurgitation, bicuspid valve disease, aortic rupture into
pericardium
Comorbidities: hypertension, coronary artery disease, previ-
ous myocardial infarction, electrocardiographically determined
ST-segment elevation or depression, dyslipidemia, chronic
heart failure, chronic obstructive pulmonary disease, smoking,
peripheral vascular disease, Marfan disease, previous cardiac
surgery, previous vascular surgery, serum creatinine level
Procedure
Cardiopulmonary bypass: cardiopulmonary bypass and
crossclamp time, use of circulatory arrest and its duration
Operation: type of procedure performed (ascending aorta
replacement [AAR] without valve procedure, AAR with ei-
ther composite root replacement or aortic valve replacement,
or AAR with aortic valve resuspension), hemiarch or total
arch repair, open distal anastomosis, use of biologic glue,
use of antifibrinolytic agent
Year of operation: years since October 1979
FIGURE E1. Survival after surgical intervention for all hospital survivors
compared with Massachusetts’ general population matched for age, sex, and
race. Actuarial survival estimates with 1 standard deviation (68% confidence
limits) and size of risk sets at 1, 5, 10, 15, and 20 years after surgical intervention
are shown in the embedded table. The predicted survival from the parametric
multiphase model is overlaid as a bold solid line in the same illustration,
with a bold dashed line indicating 1 standard deviation. The bold dotted line
represents the matched survival for the Massachusetts’ general population.
FIGURE E2. Freedom from aortic reoperation on the aorta or aortic valve
for all hospital survivors. Actuarial survival estimates with 1 standard devi-
ation (68% confidence limits) and size of risk sets at 1, 5, 10, 15, and 20
years after surgical intervention are shown in the embedded table.1357.e1 The Journal of Thoracic and Cardiovascular Surgery c December 2009
